PTPRC and fetal growth restriction: Using flow cytometry, we observed a decrease (−50%; p < 0.05) in the proportion of CD31+ versus CD146+ staining on CD45-viable cells IUGR-ECFCs compared with CTRL-ECFCs (Figure 2A–D).